A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system

Drug and Alcohol Dependence

Volumn 72, Issue 1, 2003, Pages 59-65

  Dolan, Kate A ^a   Shearer, James ^a   MacDonald, Margaret ^b   Mattick, Richard P ^a   Hall, Wayne ^c   Wodak, Alex D ^d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

Author keywords

Hepatitis C; HIV; Injections; Methadone; Prisoner; Randomised controlled trial

Indexed keywords

METHADONE; NARCOTIC AGENT;

ADULT; ARTICLE; AUSTRALIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABUSE; DRUG DEPENDENCE; FEMALE; FOLLOW UP; HAIR ANALYSIS; HEALTH PROGRAM; HEPATITIS C; HEROIN DEPENDENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; PRIORITY JOURNAL; PRISON; PRISONER; RANDOMIZED CONTROLLED TRIAL; RESIDENTIAL CARE; SELF REPORT; SEROLOGY; SYRINGE;

HEPATITIS C VIRUS;

EID: 0141918809     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(03)00187-X     Document Type: Article

References (33)

1. Breslow N.E., Day N.E. Statistical methods in cancer research. Vol II The design and analysis of cohort studies. 1987;International Agency for Research on Cancer, World Health Organization, Lyon.
2. Buavrit A., Page-Schafer K., van Griensven G., Mandel J., Evans J., Chuaratanaphong J., Chiamwongpat S., Sacks R., Moss A. Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study. Br. Med. J. 326:(7384):2003;303-312.
3. Butler T., Dolan K., Ferson M., McGuiness L., Brown P., Robertson P. Hepatitis B and C in New South Wales prisons. Prevalence and risk factors. Med. J. Aust. 166:1997;127-130.
4. Caplehorn J.R.M., Dalton M.S.Y.M., Cluff M.C., Petrenas A.M. Retention in methadone maintenance and heroin addicts' risk of death. Addiction. 89:1994;203-207.
5. Choopanya K., Des Jarlais D.C., Vanichseni S., Kitayaporn D., Mock P.A., Raktham S., Hireanras K., Heyward W.L., Sujarita S., Mastro T.D. Incarceration and risk for HIV infection among injection drug users in Bangkok. J. AIDS. 2002;86-94.
6. Christensen P.B., Krarup H.B., Niesters H.G., Norder H., Georgsen J. Prevalence and incidence of bloodborne viral infections among Danish prisoners. Eur. J. Epidemiol. 16:(11):2000;1043-1049.
7. Corben S. NSW Inmate Census 1997. Summary of Characteristics. 1997;Department of Corrective Services, Sydney NSW.
8. Corrections Health Service, 1998. Annual Report 1997-1998. NSW Department of Health, Sydney.
9. Correctional Service Canada, 1996. 1995 National Inmate Survey: Final Report. Ottawa, The Service, Correctional Research and Development.
10. Crofts N., Stewart T., Hearne P., Ping X.Y., Breshkin A., Locarnini S.A. Spread of blood borne viruses among Australian prison entrants. Br. Med. J. 310:1995;285-288.
11. Dolan K. Can Hepatitis C transmission be reduced in Australian prisons? Editorial. Med. J. Aust. 174:(8):2001;378-379.
12. Dolan K., Wodak A. An international review of methadone provision in prisons. Addict Res. 4:(1):1996;85-97.
13. Dolan K., Wodak A. HIV transmission in a prison system in an Australian state. Med. J. Aust. 171:1999;14-17.
14. Dolan K., Wodak A., Hall W., Gaughwin M., Rae F. Risk behaviour of IDUs before, during and after imprisonment in NSW. Addiction Res. 4:(2):1996;151-160.
15. Dolan K.A., Hall W., Wodak A. Methadone maintenance reduces injecting in prison. Br. Med. J. 312:1996;1162.
16. Dolan K., Shearer J., White B., Wodak A. A randomised controlled trial of methadone maintenance treatment in NSW prisons Technical Report No. 155. 2003;National Drug and Alcohol Research Centre, Sydney.
17. Dole V.P., Robinson J.W., Orraca J., Towns E., Searcy P., Caine E. Methadone treatment of randomly selected criminal addicts. New Eng. J. Med. 280:(25):1969;1372-1375.
18. Gore S.M., Bird A.G., Burns S.M., Goldberg D.J., Ross A.J., Macgregor J. Drug injection and HIV prevalence in inmates of Glenochil prison. Br. Med. J. 310:1995;293-296.
19. Gottheil E., Sterling R.C., Weinstein S.P. Diminished illicit drug use as a consequence of long-term methadone maintenance. J. Addict. Dis. 12:(4):1993;45.
20. Hall W., Ward J., Mattick R. Methadone maintenance treatment in prisons: the New South Wales experience. Drug Alcohol Rev. 12:1993;193-203.
21. Hedouin V., Gosset D. Infection with hepatitis C virus in a prison environment. A prospective study in Loos-lez-Lille, France. Gastroenterol. Clin. Biol. 22:(1):1998;55-58.
22. Magura S., Rosenblum A., Lewis C., Joseph H. The effectiveness of in-jail methadone maintenance. J. Drug Issues. 23:(1):1993;75-99.
23. Malliori M., Sypsa V., Psichogiou M. A survey of bloodborne viruses and associated risk behaviours in Greek prisons. Addiction. 93:(2):1998;243-251.
24. Metzger D.S., Woody G.E., McLellan A.T., O'Brian C.P., Druley P., et al. Human Immunodeficiency virus seroconversion among intravenous drug users in- and out- of treatment: an 18 month prospective follow-up. J. AIDS. 6:1993;1049-1055.
25. National Centre in HIV Epidemiology and Clinical Research (NCHECR), 2001. Annual Surveillance Report 2000: HIV/AIDS, hepatitis C and sexually transmissible infections in Australia. National Centre in HIV Epidemiology and Clinical Research, Sydney.
26. National Committees for Clinical Laboratory Standards (NCCLS), 1988. Blood collection of filter-paper for neonatal screening programs. Centres for Disease Control, The Massachusetts Departments of Public Health, the New York State Department of Public Health and the National Institutes of Health. LA4-A 1988.
27. Newman R.G., Bashkow S., Cates M. Arrest histories before and after admission to a methadone maintenance program. Contemp. Drug Problems. Fall:1973;417-430.
28. Post J.J., Dolan K.A., Whybin L.R., Carter I.W.J., Haber P.S., Lloyd A.R. Acute hepatitis C virus infection in an Australian prison inmate: tattooing as a possible transmission route. Med. J. Aust. 174:2001;183-184.
29. Sees K.L., Delucchi K.L., Masson C., Rosen A., Clark H.W., Robillard H., Banys P., Hall S.M. Methadone maintenance vs. 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. J. Am. Med. Assoc. 283:(10):2000;1303-1310.
30. Stark K., Bienzle U., Vonk R., Guggenmoos-Holzman I. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and HIV infection among injecting drug users in Berlin. Int. J. Epidemiol. 26:(6):1997;1359-1366.
31. Taylor A., Goldberg D., Emslie J., Wrench J., Gruer L., et al. Outbreak of HIV infection in a Scottish Prison. Br. Med. J. 310:1995;289-292.
32. United Nations International Drug Control Programme, 1998. Guidelines for Testing Drugs Under International Control in Hair, Sweat and Saliva. United Nations, New York.
33. Vlahov D., Nelson K.E., Quinn T.C., Kendig N. Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland. Eur. J. Epidemiol. 9:(5):1993;566-569.